コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ariable ectopic mineralization phenotypes of pseudoxanthoma elasticum.
2 neralization in an Abcc6(-/-) mouse model of pseudoxanthoma elasticum.
3 tion to counteract ectopic mineralization in pseudoxanthoma elasticum.
4 efore provides a novel model system to study pseudoxanthoma elasticum.
5 ssion system in an Abcc6(-/-) mouse model of pseudoxanthoma elasticum.
6 evels underlie the ectopic mineralization in pseudoxanthoma elasticum.
7 issense variants identified in patients with pseudoxanthoma elasticum.
8 rter C6) ABC transporter are associated with pseudoxanthoma elasticum, a disease of altered elastic p
9 drug efflux pumps, are the genetic basis of Pseudoxanthoma elasticum, a disease that affects elastin
14 eye (3%) had neovascularization secondary to pseudoxanthoma elasticum, all showing similar ORT format
15 f all Vanderbilt Eye Institute patients with pseudoxanthoma elasticum and at least 1 set of color fun
16 early, is a promising prevention therapy for pseudoxanthoma elasticum and generalized arterial calcif
18 els, resulting in the calcification disorder pseudoxanthoma elasticum and some cases of generalized a
19 nderlie the incurable calcification disorder pseudoxanthoma elasticum and some cases of generalized a
20 f-function mutations in the ABCC6 gene cause pseudoxanthoma elasticum and type 2 generalized arterial
22 ic atrophy independent of CNV can develop in pseudoxanthoma elasticum, causing significant vision los
23 ted a series of Abcc6(-/-) rats as models of pseudoxanthoma elasticum depicting ectopic mineralizatio
24 exemplified by familial tumoral calcinosis, pseudoxanthoma elasticum, generalized arterial calcifica
25 genic disorders of pathologic calcification: pseudoxanthoma elasticum, generalized arterial calcifica
26 dietary preferences of patients may explain pseudoxanthoma elasticum heterogeneous manifestations, a
29 remains unknown, recent studies showed that pseudoxanthoma elasticum is a metabolic disorder caused
36 several months prevented the development of pseudoxanthoma elasticum-like spontaneous calcification,
38 mately 200 mutations have been identified in pseudoxanthoma elasticum patients, the underlying struct
40 BCC6 gene cause soft-tissue calcification in pseudoxanthoma elasticum (PXE) and, in some patients, ge
41 iations cause the calcification phenotype of pseudoxanthoma elasticum (PXE) as well as some cases of
60 rformed linkage analysis on 21 families with pseudoxanthoma elasticum (PXE) using 10 polymorphic mark
61 cular fundus abnormalities characteristic of pseudoxanthoma elasticum (PXE) were detected by cSLO in
62 cause of a relatively frequent inborn error, pseudoxanthoma elasticum (PXE), a disorder resulting in
63 ecular basis and pathomechanistic details in pseudoxanthoma elasticum (PXE), a heritable multisystem
74 ients with angioid streaks (AS) secondary to pseudoxanthoma elasticum (PXE), and to introduce a clini
75 A), Stargardt disease (STGD1), Best disease, pseudoxanthoma elasticum (PXE), central areolar choroida
77 cular fundus abnormalities characteristic of pseudoxanthoma elasticum (PXE), including peau d'orange,
80 To better understand the pathogenetics of pseudoxanthoma elasticum (PXE), we performed a mutationa
82 ion to mitigate calcification progression in pseudoxanthoma elasticum, that dietary preferences of pa
83 ions in four candidate genes associated with pseudoxanthoma elasticum, the prototype of ectopic miner
86 The fundamental question on pathogenesis of pseudoxanthoma elasticum, whether lack of ABCC6 expressi